Site-specific engineering of S-Te-S bridged nano-prodrug: A dual equilibrium strategy for enhanced antitumor efficacy and safety of paclitaxel
- DOI
- 10.1016/j.jconrel.2025.114174
- Published
- 2025-11
- Container
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jconrel.2025.114174,
title = {Site-specific engineering of S-Te-S bridged nano-prodrug: A dual equilibrium strategy for enhanced antitumor efficacy and safety of paclitaxel},
author = {Mengyuan Duan and Yingjie Zhao and Hao Zhang and Chengde Jiang and Mengyu Liu and Jingyi Zhang and Shuo Wang and Yongke Zhang and Xinxin Deng and Jin Sun and Bingjun Sun and Zhonggui He and Tian Liu},
year = {2025},
journal = {Journal of Controlled Release},
doi = {10.1016/j.jconrel.2025.114174},
url = {https://doi.org/10.1016/j.jconrel.2025.114174}
}RIS
TY - JOUR TI - Site-specific engineering of S-Te-S bridged nano-prodrug: A dual equilibrium strategy for enhanced antitumor efficacy and safety of paclitaxel AU - Mengyuan Duan AU - Yingjie Zhao AU - Hao Zhang AU - Chengde Jiang AU - Mengyu Liu AU - Jingyi Zhang AU - Shuo Wang AU - Yongke Zhang AU - Xinxin Deng AU - Jin Sun AU - Bingjun Sun AU - Zhonggui He AU - Tian Liu PY - 2025 JO - Journal of Controlled Release DO - 10.1016/j.jconrel.2025.114174 UR - https://doi.org/10.1016/j.jconrel.2025.114174 ER -
APA
Duan, M., Zhao, Y., Zhang, H., Jiang, C., Liu, M., Zhang, J., Wang, S., Zhang, Y., Deng, X., Sun, J., Sun, B., He, Z., & Liu, T. (2025). Site-specific engineering of S-Te-S bridged nano-prodrug: A dual equilibrium strategy for enhanced antitumor efficacy and safety of paclitaxel. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.114174
Source records
- crossref · retrieved 2026-09-25T06:09:20.329Z